CP-778,875
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CP-778,875, covering 2009-05-07 to 2009-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes. [Phase 2]